TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CDXS

Codexis Inc

Healthcare · Biotechnology

1.40$ +3.0% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Codexis Inc (CDXS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 70 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement CDXS
Line item 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
12 25 50 83 107 124 88 32 35 42 49 50 61 68 69 105 139 70 59 70
1.8 8.3 13 17 28 42 31 15 9.7 6.6 9.8 14 13 16 14 22 38 13 16 9.3
10 17 37 66 79 82 58 17 26 35 39 36 48 53 55 83 101 57 43 61
17 36 46 55 52 61 57 32 23 21 22 30 30 34 44 56 80 59 46 52
12 20 36 30 34 37 31 26 22 22 25 29 29 32 35 49 52 53 55 47
29 55 81 85 86 98 88 59 45 43 48 59 59 65 79 105 135 125 102 99
-19 -38 -44 -18 -7.1 -16 -31 -41 -19 -7.8 -8.6 -23 -11 -13 -24 -23 -35 -68 -59 -38
0.7 2.5 2.4 2.0 0.5 0.7 0.3 0.3 0.0 0.0 0.1 0.1 0.7 5.2 4.8 7.6 1.4 12 10 4.8
-19 -39 -45 -20 -8.2 -16 -31 -41 -19 -7.9 -8.6 -23 -11 -12 -24 -21 -33 -76 -65 -44
-0.1 -0.4 0.3 0.1 0.4 0.2 0.3 -0.1 -0.3 -0.3 0.0 0.1 0.0 0.0 0.3 0.2 0.3 0.1 0.0 0.0
-19 -39 -45 -20 -8.5 -17 -31 -41 -19 -7.6 -8.6 -23 -11 -12 -24 -21 -34 -76 -65 -44
-16 -35 -38 -12 0.7 -4.8 -18 -31 -12 -2.4 -4.0 -22 -10 -8.0 -19 -17 -26 -49 -53 -34

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?